{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:34:11Z","timestamp":1786980851891,"version":"build-2736575974"},"reference-count":17,"publisher":"Wiley","issue":"S2","license":[{"start":{"date-parts":[[2008,7,12]],"date-time":"2008-07-12T00:00:00Z","timestamp":1215820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["VZ 00064165"],"award-info":[{"award-number":["VZ 00064165"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Inher Metab Disea"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:p>\n                    Deficiency of adenylosuccinate lyase (ADSL) (OMIM 103050) is an autosomal recessive disorder of the purine\n                    <jats:italic>de novo<\/jats:italic>\n                    synthesis pathway and purine nucleotide cycle, diagnosed so far in approximately 50 patients. The clinical presentation is characterized by severe neurological involvement including hypotonia, seizures, developmental delay and autistic features. Epilepsy in ADSL deficiency is frequent and occurs in approximately two\u2010thirds of patients, beginning either early in the neonatal period or after the first year of life. At present there is no treatment of proven clinical efficacy. Despite of the increasing number of ADSL\u2010deficient patients reported, there are only a few communications of therapeutic considerations or efforts. Among them only two showed some beneficial effects in ADSL\u2010deficient patients.\n                    <jats:sc>d<\/jats:sc>\n                    \u2010Ribose, a simple and relatively cheap therapy, has been associated with improvement of behaviour and progressive reduction of the seizure frequency in one 13\u2010year\u2010old patient with ADSL deficiency. In this study we have re\u2010examined\n                    <jats:sc>d<\/jats:sc>\n                    \u2010ribose treatment in four ADSL\u2010deficient patients. Assessments consisted of biochemical markers and neurological outcome. The 12\u2010month trial of\n                    <jats:sc>d<\/jats:sc>\n                    \u2010ribose failed to show any clinical benefit in ADSL patients with both milder and severe phenotype.\n                    <jats:sc>d<\/jats:sc>\n                    \u2010Ribose administration was accompanied by neither reduction in seizure frequency nor growth enhancement. Additionally, patients with milder type II presented the first seizure after 4 and 8 months of the\n                    <jats:sc>d<\/jats:sc>\n                    \u2010ribose treatment. Therefore, we could not confirm a positive effect of\n                    <jats:sc>d<\/jats:sc>\n                    \u2010ribose as previously reported.\n                  <\/jats:p>","DOI":"10.1007\/s10545-008-0904-z","type":"journal-article","created":{"date-parts":[[2008,7,21]],"date-time":"2008-07-21T14:09:47Z","timestamp":1216649387000},"page":"329-332","source":"Crossref","is-referenced-by-count":23,"title":["<scp>d<\/scp>\n                    \u2010Ribose therapy in four Polish patients with adenylosuccinate lyase deficiency: Absence of positive effect"],"prefix":"10.1002","volume":"31","author":[{"given":"A.","family":"Jurecka","sequence":"first","affiliation":[{"name":"Department of Metabolic Diseases, Endocrinology and Diabetology The Children's Memorial Health Institute Al. Dzieci Polskich 20 Warsaw 04\u2010730 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Tylki\u2010Szymanska","sequence":"additional","affiliation":[{"name":"Department of Metabolic Diseases, Endocrinology and Diabetology The Children's Memorial Health Institute Al. Dzieci Polskich 20 Warsaw 04\u2010730 Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Zikanova","sequence":"additional","affiliation":[{"name":"Institute for Inherited Metabolic Disorders Charles University, 1st Faculty of Medicine Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Krijt","sequence":"additional","affiliation":[{"name":"Institute for Inherited Metabolic Disorders Charles University, 1st Faculty of Medicine Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kmoch","sequence":"additional","affiliation":[{"name":"Institute for Inherited Metabolic Disorders Charles University, 1st Faculty of Medicine Prague Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,7,12]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-34493"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1177\/088307380101600501"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00442515"},{"issue":"8411","key":"e_1_2_6_5_1","first-page":"1058","article-title":"An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids","volume":"2","author":"Jaeken J","year":"1984","journal-title":"Lancet"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00445919"},{"key":"e_1_2_6_7_1","first-page":"126","article-title":"Clinical, biochemical and molecular findings in seven Polish patients with adenylosuccinate lyase deficiency","volume":"148","author":"Jurecka A","year":"2008","journal-title":"Mol Genet Metab"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(99)00024-9"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1081\/NCN-200027641"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2006.09.027"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5381-6_34"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/0-306-46843-3_14"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103658"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2006.04.018"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-200003000-00007"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-5381-6_36"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1991.261.2.C342"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-973536"}],"container-title":["Journal of Inherited Metabolic Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-008-0904-z","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1007\/s10545-008-0904-z","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1007\/s10545-008-0904-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:23:11Z","timestamp":1694737391000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1007\/s10545-008-0904-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,12]]},"references-count":17,"journal-issue":{"issue":"S2","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1007\/s10545-008-0904-z"],"URL":"https:\/\/doi.org\/10.1007\/s10545-008-0904-z","archive":["Portico"],"relation":{},"ISSN":["0141-8955","1573-2665"],"issn-type":[{"value":"0141-8955","type":"print"},{"value":"1573-2665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,12]]}}}